MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202527053978 A) filed by Nanostics Inc., Edmonton, Canada, on June 4, for 'clinical analysis and methods for predicting the risk of developing clinically significant prostate cancer.'

Inventor(s) include Lewis, John; and Paproski, Robert.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "This invention relates to a method, a non-transitory computer readable medium and a system for predicting the risk of developing clinically significant prostate cancer. A plurality of patients are selected based on a set of pre-determined criteria and clinical dat...